These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1955050

  • 1. Use of steroids and immunosuppressive drugs in the management of posterior uveitis.
    Lightman S.
    Eye (Lond); 1991; 5 ( Pt 3)():294-8. PubMed ID: 1955050
    [Abstract] [Full Text] [Related]

  • 2. [Medical treatment of severe uveitis].
    Berche M, Najjar G, Renard Y, Darwiche A, Musitelli E.
    Ophtalmologie; 1989; 3(1):37-9. PubMed ID: 2641067
    [Abstract] [Full Text] [Related]

  • 3. New therapeutic options in uveitis.
    Lightman S.
    Eye (Lond); 1997; 11 ( Pt 2)():222-6. PubMed ID: 9349417
    [Abstract] [Full Text] [Related]

  • 4. The diagnosis and management of uveitis.
    Anglade E, Whitcup SM.
    Drugs; 1995 Feb; 49(2):213-23. PubMed ID: 7729329
    [Abstract] [Full Text] [Related]

  • 5. [Immunosuppressive therapy in clinical practice].
    Frey FJ.
    Schweiz Med Wochenschr; 1987 May 23; 117(21):810-5. PubMed ID: 3589636
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
    Franzolini N, Quartuccio L, De Marchi G, De Vita S.
    Reumatismo; 2007 May 23; 59(3):202-8. PubMed ID: 17898879
    [Abstract] [Full Text] [Related]

  • 7. Low dose cyclosporin A therapy in chronic posterior uveitis.
    Towler HM, Cliffe AM, Whiting PH, Forrester JV.
    Eye (Lond); 1989 May 23; 3 ( Pt 3)():282-7. PubMed ID: 2612672
    [Abstract] [Full Text] [Related]

  • 8. [Immunosuppression--a tightrope walk between iatrogenic harm and therapy].
    Berchtold P, Seitz M.
    Schweiz Med Wochenschr; 1996 Sep 21; 126(38):1603-9. PubMed ID: 8927965
    [Abstract] [Full Text] [Related]

  • 9. Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).
    Benitez-del-Castillo JM, Martinez-de-la-Casa JM, Pato-Cour E, Méndez-Fernández R, López-Abad C, Matilla M, Garcia-Sanchez J.
    Eye (Lond); 2005 Aug 21; 19(8):841-5. PubMed ID: 15389273
    [Abstract] [Full Text] [Related]

  • 10. [Plasmapheresis and acute attacks of uveitis].
    Malecaze F, Mathis A, Goudable C, Maillard P, Fabre L, Bec P.
    Ophtalmologie; 1989 Aug 21; 3(1):43-5. PubMed ID: 2641070
    [Abstract] [Full Text] [Related]

  • 11. Treatment of Behçet's disease--an update.
    Kaklamani VG, Kaklamanis PG.
    Semin Arthritis Rheum; 2001 Apr 21; 30(5):299-312. PubMed ID: 11303303
    [Abstract] [Full Text] [Related]

  • 12. [Effectiveness of interferon alpha in the treatment of uveitis macular edema refractory to corticosteroid and/or immunosuppressive treatment].
    Paire V, Lebreton O, Weber M.
    J Fr Ophtalmol; 2010 Mar 21; 33(3):152-62. PubMed ID: 20181409
    [Abstract] [Full Text] [Related]

  • 13. [Classical immunosuppressive agents].
    Martenet AC.
    Bull Soc Belge Ophtalmol; 1989 Mar 21; 230():135-41. PubMed ID: 2488429
    [Abstract] [Full Text] [Related]

  • 14. [Indications for immunosuppressive agents in glomerular nephropathies].
    Méry JP, Girard JF.
    Ann Med Interne (Paris); 1974 Nov 21; 125(11):795-802. PubMed ID: 4460826
    [No Abstract] [Full Text] [Related]

  • 15. Treating chronic noninfectious posterior segment uveitis: the impact of cumulative damage. Proceedings of an expert panel roundtable discussion.
    Nguyen QD, Callanan D, Dugel P, Godfrey DG, Goldstein DA, Wilensky JT.
    Retina; 2006 Oct 21; Suppl():1-16. PubMed ID: 17050954
    [Abstract] [Full Text] [Related]

  • 16. [Therapy of lupus-nephritis using corticosteroids and immunosuppressive agents].
    Kampf D, Baethke R.
    Dtsch Med Wochenschr; 1974 Jun 28; 99(26):1420-3. PubMed ID: 4135099
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I, Mudun A, Urgancioglu M, Kamali S, Kasapoglu E, Inanc M, Gül A.
    Arthritis Rheum; 2005 Aug 28; 52(8):2478-84. PubMed ID: 16052571
    [Abstract] [Full Text] [Related]

  • 18. [Therapy of endogenous uveitis. Immunosuppression].
    Martenet AC.
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1980 Aug 28; 78():223-8. PubMed ID: 7039605
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
    Lopez-Gonzalez R, Loza E, Jover JA, Benitez Del Castillo JM, Mendez R, Hernandez-Garcia C, Pato E.
    Scand J Rheumatol; 2009 Aug 28; 38(1):58-62. PubMed ID: 18991187
    [Abstract] [Full Text] [Related]

  • 20. Immunosuppression in uveitis therapy.
    Van Gelder RN, Kaplan HJ.
    Springer Semin Immunopathol; 1999 Aug 28; 21(2):179-90. PubMed ID: 10457590
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.